<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/63A7C928-3A19-4C14-812F-370961534DAC"><gtr:id>63A7C928-3A19-4C14-812F-370961534DAC</gtr:id><gtr:name>John Innes Centre</gtr:name><gtr:department>Biological Chemistry</gtr:department><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:line3>Norwich</gtr:line3><gtr:line4>Norwich</gtr:line4><gtr:postCode>NR4 7UH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/63A7C928-3A19-4C14-812F-370961534DAC"><gtr:id>63A7C928-3A19-4C14-812F-370961534DAC</gtr:id><gtr:name>John Innes Centre</gtr:name><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:line3>Norwich</gtr:line3><gtr:line4>Norwich</gtr:line4><gtr:postCode>NR4 7UH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/04D76F30-BDEF-45A1-82ED-3946C84E9824"><gtr:id>04D76F30-BDEF-45A1-82ED-3946C84E9824</gtr:id><gtr:firstName>Rob</gtr:firstName><gtr:surname>Field</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7C798542-D109-4562-A9E5-9D9B5A3B1F91"><gtr:id>7C798542-D109-4562-A9E5-9D9B5A3B1F91</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Searcey</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FM021769%2F1"><gtr:id>B4D770C0-81B4-41A7-BF24-200A5932DBFE</gtr:id><gtr:title>Glyconanoparticle diagnostics for the detection and discrimation of human and avian influenza infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/M021769/1</gtr:grantReference><gtr:abstractText>Recurring incidents of avian and swine flu infection in humans have prompted the development of novel, accurate point-of-care diagnostics for influenza. Current methods for the detection of influenza all take at least several hours and require specialist equipment and trained analysts. Rapid diagnostic tests do exist, but all are relatively crude and unable to distinguish between seasonal, pandemic and animal strains of influenza virus. The aim of this project is to develop a simple diagnostic test, based on practical and inexpensive gold nanoparticle-based colorimetric assays. Gold nanoparticles in aqueous solution exhibit an intense red colour that upon clustering of the nanoparticles changes colour to purple - readily observed with the naked eye. By functionalising gold nanoparticles with specific carbohydrate ligands, glyconanoparticles capable of clustering on flu virus surfaces will be developed, thus detecting and discriminating between human and animal strains.</gtr:abstractText><gtr:fund><gtr:end>2017-04-14</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2015-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>193837</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>New ligands for flu sensors have been synthesised</gtr:description><gtr:exploitationPathways>Super follow-on fund bid under consideration</gtr:exploitationPathways><gtr:id>CF3023C0-E1BF-4B9E-8D2F-08C87E5C0E5C</gtr:id><gtr:outcomeId>56ddf61c1aa866.29869458</gtr:outcomeId><gtr:sectors><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Iceni Diagnostics Ltd</gtr:companyName><gtr:description>Iceni Diagnsoptics offers bespoke solutions to third parties with requirement in carbohydrate and bioconjugation chemistry. It also has an in house program of glycodiagnostics development.</gtr:description><gtr:id>B9D398D6-AB8B-42C6-A886-14E2363305EA</gtr:id><gtr:impact>Too early</gtr:impact><gtr:outcomeId>56ddf86bb00431.18852763</gtr:outcomeId><gtr:yearCompanyFormed>2014</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>0D7E5DA6-4B0F-422D-AA69-869C8AA0B579</gtr:id><gtr:title>Detection of mSiglec-E, in solution and expressed on the surface of Chinese hamster ovary cells, using sialic acid functionalised gold nanoparticles.</gtr:title><gtr:parentPublicationTitle>The Analyst</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6003c5a94a3c192548192086e88e8c8"><gtr:id>b6003c5a94a3c192548192086e88e8c8</gtr:id><gtr:otherNames>Schofield CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0003-2654</gtr:issn><gtr:outcomeId>58bc0f430439c6.12612872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FB7631E-7A12-41A0-80D4-7152C888A1D2</gtr:id><gtr:title>Glyconanoparticles for colorimetric bioassays.</gtr:title><gtr:parentPublicationTitle>The Analyst</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17bc5fd6a79c175e734b1be62ff1ed5a"><gtr:id>17bc5fd6a79c175e734b1be62ff1ed5a</gtr:id><gtr:otherNames>Mar?n MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0003-2654</gtr:issn><gtr:outcomeId>56ddfe5c6a5a16.73196504</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>071DD5F3-EEB2-490C-9C2C-8D449C741139</gtr:id><gtr:title>Carbohydrate CuAAC click chemistry for therapy and diagnosis.</gtr:title><gtr:parentPublicationTitle>Carbohydrate research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11461479f0e0d6e11de64be187e9bdf4"><gtr:id>11461479f0e0d6e11de64be187e9bdf4</gtr:id><gtr:otherNames>He XP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0008-6215</gtr:issn><gtr:outcomeId>58bc0f44199dc9.06092909</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/M021769/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>